Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 29-May-24 7:21 PM View:  | Rigel Pharmaceuticals, Inc. (RIGL) | 25-May-24 | Grant | 25,000 | -- | -- | 33% 75.0K to 100.0K | |
| 25-Jan-24 6:02 AM View: | Galena Biopharma, Inc. (SLS) | 22-Jan-24 | Grant | 6,000 | -- | -- | 136% 4.4K to 10.4K | |
| 12-Jul-23 6:45 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 26-May-23 | Grant | 25,000 | -- | -- | 50% 50.0K to 75.0K | |
| 03-Feb-23 5:13 PM View: | Galena Biopharma, Inc. (SLS) | 02-Feb-23 | Grant | 2,500 | -- | -- | 132% 1.9K to 4.4K | |
| 11-Jan-23 12:30 PM View: | Athersys, Inc. (ATHX) | 09-Jan-23 | Grant | 22,321 | -- | -- | 174% 12.82K to 35.14K | |
| 20-Sep-22 1:39 PM View: | Athersys, Inc. (ATHX) | 16-Sep-22 | Grant | 12,820 | -- | -- | 100% 0 to 12.82K | |
| 23-May-22 5:50 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 20-May-22 | Grant | 25,000 | -- | -- | 100% 25.0K to 50.0K | |
| 01-Feb-22 5:07 PM View: | Galena Biopharma, Inc. (SLS) | 31-Jan-22 | Grant | 1,900 | -- | -- | 100% 0 to 1.9K | |
| 21-May-21 9:03 PM View: | Rigel Pharmaceuticals, Inc. (RIGL) | 19-May-21 | Grant | 25,000 | -- | -- | 100% 0 to 25.0K | |
| 04-Dec-19 7:53 AM View: | Acorda Therapeutics, Inc. (ACOR) | 02-Dec-19 | Market Sale (Planned) | 2,227 | $1.60 | $3,552.73 | (2%) 119.65K to 117.42K | 54% |
| 12-Mar-19 4:25 PM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-19 | Grant | 12,813 | -- | -- | 12% 106.83K to 119.65K | |
| 25-Feb-19 4:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 21-Feb-19 | Payment of Exercise | 953 | $13.38 | $12,751.10 | (< 1%) 107.79K to 106.83K | 95% |
| 27-Dec-18 8:16 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-18 | Grant | 2,500 | -- | -- | 2% 105.29K to 107.79K | |
| 06-Dec-18 8:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Dec-18 | Market Sale (Planned) | 3,067 | $20.52 | $62,947.40 | (3%) 108.35K to 105.29K | 96% |
| 07-Nov-18 4:13 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Nov-18 | Payment of Exercise | 955 | $20.28 | $19,367.40 | (< 1%) 109.31K to 108.35K | 96% |
| 12-Sep-18 4:21 PM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Sep-18 | Grant | 2,500 | -- | -- | 2% 106.81K to 109.31K | |
| 12-Mar-18 8:40 AM View: | Acorda Therapeutics, Inc. (ACOR) | 08-Mar-18 | Payment of Exercise | 2,470 | $25.65 | $63,355.50 | (2%) 109.28K to 106.81K | 97% |
| 07-Mar-18 7:54 AM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-18 | Payment of Exercise | 2,274 | $25.95 | $59,010.30 | (2%) 111.55K to 109.28K | 97% |
| 07-Mar-18 7:54 AM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Mar-18 | Option Exercise | 2,980 | $19.81 | $59,033.80 | 3% 108.57K to 111.55K | |
| 26-Feb-18 8:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Feb-18 | Grant | 6,463 | -- | -- | 6% 102.11K to 108.57K | |
| 23-Jan-18 7:52 AM View: | Acorda Therapeutics, Inc. (ACOR) | 19-Jan-18 | Option Exercise | 34,520 | $19.81 | $683,841.00 | 34% 102.11K to 136.63K | |
| 23-Jan-18 7:52 AM View: | Acorda Therapeutics, Inc. (ACOR) | 19-Jan-18 | Market Option Sale (Planned) | 34,520 | $27.59 | $952,319.00 | (25%) 136.63K to 102.11K | 97% |
| 05-Dec-17 7:46 AM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-17 | Market Sale (Planned) | 4,564 | $20.52 | $93,662.40 | (4%) 106.67K to 102.11K | 96% |
| 03-Mar-17 4:38 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Mar-17 | Grant | 5,000 | -- | -- | 5% 101.67K to 106.67K | |
| 13-Feb-17 4:16 PM View: | Acorda Therapeutics, Inc. (ACOR) | 09-Feb-17 | Option Exercise | 54,536 | $22.13 | $1,206,880.00 | 54% 101.67K to 156.21K | (97%) |
| 13-Feb-17 4:16 PM View: | Acorda Therapeutics, Inc. (ACOR) | 09-Feb-17 | Market Option Sale (Planned) | 54,536 | $22.30 | $1,216,220.00 | (35%) 156.21K to 101.67K | 97% |
| 05-Dec-16 5:15 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-16 | Market Sale (Planned) | 3,347 | $20.74 | $69,400.00 | (3%) 105.02K to 101.67K | 96% |
| 05-Oct-16 4:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Oct-16 | Market Sale (Planned) | 3,750 | $20.78 | $77,926.90 | (3%) 108.77K to 105.02K | 96% |
| 27-Sep-16 8:01 AM View: | Acorda Therapeutics, Inc. (ACOR) | 23-Sep-16 | Option Exercise | 500 | $8.50 | $4,250.00 | < 1% 108.77K to 109.27K | |
| 27-Sep-16 8:01 AM View: | Acorda Therapeutics, Inc. (ACOR) | 23-Sep-16 | Market Option Sale (Planned) | 500 | $27.32 | $13,660.30 | (< 1%) 109.27K to 108.77K | 97% |
| 14-Jun-16 8:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 10-Jun-16 | Option Exercise | 8,647 | $22.13 | $191,358.00 | 9% 100.12K to 108.77K | |
| 28-Dec-15 7:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 23-Dec-15 | Option Exercise | 10,751 | $5.85 | $62,893.30 | 11% 100.12K to 110.88K | |
| 28-Dec-15 7:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 23-Dec-15 | Market Option Sale (Planned) | 10,751 | $43.10 | $463,395.00 | (10%) 110.88K to 100.12K | 98% |
| 24-Dec-15 8:04 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-15 | Option Exercise | 5,342 | $5.85 | $31,250.70 | 5% 108.58K to 113.92K | |
| 24-Dec-15 8:04 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-15 | Market Option Sale (Planned) | 5,342 | $42.43 | $226,671.00 | (5%) 113.92K to 108.58K | 98% |
| 24-Dec-15 8:04 AM View: | Acorda Therapeutics, Inc. (ACOR) | 22-Dec-15 | Market Sale (Planned) | 8,455 | $42.43 | $358,761.00 | (8%) 108.58K to 100.12K | 98% |
| 22-Dec-15 11:42 AM View: | Acorda Therapeutics, Inc. (ACOR) | 21-Dec-15 | Market Sale (Planned) | 817 | $42.00 | $34,314.00 | (< 1%) 109.4K to 108.58K | 98% |
| 21-Dec-15 4:17 PM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Dec-15 | Option Exercise | 3,277 | $6.00 | $19,662.00 | 3% 109.4K to 112.67K | |
| 21-Dec-15 4:17 PM View: | Acorda Therapeutics, Inc. (ACOR) | 17-Dec-15 | Market Option Sale (Planned) | 3,277 | $40.00 | $131,080.00 | (3%) 112.67K to 109.4K | 98% |
| 03-Dec-15 4:45 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-15 | Market Sale (Planned) | 5,523 | $38.08 | $210,294.00 | (5%) 114.92K to 109.4K | 98% |
| 06-Nov-15 7:36 AM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Nov-15 | Option Exercise | 16,822 | $5.92 | $99,595.90 | 17% 98.1K to 114.92K | |
| 06-Oct-15 8:22 PM View: | Acorda Therapeutics, Inc. (ACOR) | 05-Oct-15 | Market Sale (Planned) | 3,750 | $31.75 | $119,072.00 | (4%) 101.85K to 98.1K | 98% |
| 06-Mar-15 6:32 PM View: | Acorda Therapeutics, Inc. (ACOR) | 04-Mar-15 | Grant | 7,269 | -- | -- | 8% 94.58K to 101.85K | |
| 03-Dec-14 9:18 PM View: | Acorda Therapeutics, Inc. (ACOR) | 01-Dec-14 | Market Sale (Planned) | 6,956 | $35.58 | $247,471.00 | (7%) 101.53K to 94.58K | 98% |
| 05-Nov-14 4:09 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Nov-14 | Option Exercise | 14,923 | $8.14 | $121,473.00 | 15% 101.53K to 116.46K | |
| 05-Nov-14 4:09 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Nov-14 | Market Option Sale (Planned) | 14,923 | $34.84 | $519,949.00 | (13%) 116.46K to 101.53K | 98% |
| 07-Oct-14 4:25 PM View: | Acorda Therapeutics, Inc. (ACOR) | 03-Oct-14 | Market Sale (Planned) | 3,750 | $34.13 | $127,983.00 | (4%) 105.28K to 101.53K | 98% |
| 26-Sep-14 4:29 PM View: | Acorda Therapeutics, Inc. (ACOR) | 24-Sep-14 | Option Exercise | 14,923 | $8.14 | $121,473.00 | 14% 105.28K to 120.21K | |
| 26-Sep-14 4:29 PM View: | Acorda Therapeutics, Inc. (ACOR) | 24-Sep-14 | Market Option Sale (Planned) | 14,923 | $36.00 | $537,228.00 | (12%) 120.21K to 105.28K | 98% |
| 29-Aug-14 7:46 AM View: | Acorda Therapeutics, Inc. (ACOR) | 27-Aug-14 | Option Exercise | 14,923 | $8.14 | $121,473.00 | 14% 105.28K to 120.21K |